Remo Testini says he has to use GPS to find washroom locations on his route before he leaves home each day. Continue reading →

Direct fecal transplants (or fecal bacteriotherapy), where there is a transfer gut microbiota from healthy donors, have shown great promise in treating a range of diseases. An alternative name for the process is fecal microbiota transplant. Continue reading →

The COVID-19 pandemic has shifted the focus of research for scientists worldwide, probably making science nimbler once the crisis has passed. Continue reading →

Anti-toxin A or B antibodies were not associated with recurrent Clostridium difficile (C diff) infection, according to a paper published in the journal Anaerobe. Investigators from the University of Michigan retrospectively examined 275 adults with C diff infection in order to determine if the risk for recurrent C diff infection could be reduced if there were anti-toxin antibodies discovered in a serum sample within 48 hours of an index C diff episode. Patients admitted to Michigan Medicine between January and September 2016 were eligible for the study and the investigators studied their electronic health records, demographics, medial history, vital signs, and laboratory test results (only those conducted within 48 hours before and after C diff sample was gathered) Continue reading →